Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03445073

Ligand	Ligand name	Chain	PDB	Tanimoto
EAH	(5S,7E,9E,11Z,14Z)-5-hydroxyicosa-7,9,11,14-tetraenoic acid	A	3DZT	0.76
MRC	MUPIROCIN	A	1JZS	0.76
MRC	MUPIROCIN	A,T	1FFY	0.76
MRC	MUPIROCIN	A	1QU3	0.76
MRC	MUPIROCIN	A,T	1QU2	0.76
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.85
114	COMPACTIN	A,B,C,D	1HW8	0.85
PUL		A	2C78	0.81
OVA	3,4-DIHYDROXY-2-METHOXY-4-METHYL-3-[2-METHYL-3-(3-METHYL-BUT-2-ENYL) -OXIRANYL]-CYCLOHEXANONE	A	2GZ5	0.72
OVA	3,4-DIHYDROXY-2-METHOXY-4-METHYL-3-[2-METHYL-3-(3-METHYL-BUT-2-ENYL) -OXIRANYL]-CYCLOHEXANONE	A	1B59	0.72
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8P	0.76
DEB	6-DEOXYERYTHRONOLIDE B	A	1JIO	0.76
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8Q	0.76
DEB	6-DEOXYERYTHRONOLIDE B	A	1OXA	0.76
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8O	0.76
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.79
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.79
HEQ	3-[18-(4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-1-ENYL)-3,7,12,16-TETRAMETHYL-OCTADECA-1,3,5,7,9,11,13,15, 17-NONAENYL]-2,4,4-TRIMETHYL-CYCLOHEX-2-ENONE	A,B	1M98	0.7
E7B		A,B	3E7B	0.73
RCL	RICINOLEIC ACID	A	2CM4	0.7
RCL	RICINOLEIC ACID	A	2CM9	0.7
RCL	RICINOLEIC ACID	A	1FK7	0.7
SPX	SPHINXOLIDE B	A	2ASO	0.75
GMM	GLUCOSE MONOMYCOLATE	A	1UQS	0.76
SWI	SWINHOLIDE A	A,B	1YXQ	0.74
NRB	NARBOMYCIN	A,B	2VZM	0.71
NRB	NARBOMYCIN	A	2C7X	0.71
ENX	ENACYLOXIN IIA	A,B	2BVN	0.71
ENX	ENACYLOXIN IIA	A,B,C,D,E,F	1OB5	0.71
13T	13-DEOXYTEDANOLIDE	0,1,3,9,A,B,C,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	2OTJ	0.77
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.71
FUG	FUMAGILLIN	A,B	3FMQ	0.73
FUG	FUMAGILLIN	A	1BOA	0.73
SXN	Salinixanthin	A,B	3DDL	0.74
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.77
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2C6H	0.73
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2CA0	0.73
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2CD8	0.73
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2VZ7	0.73
OLC	(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate	A	3D4S	0.71
164	2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID	A	1R6W	0.79
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.83
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.72
MVB	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	A,B,C	1YA8	0.8
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.91
RGC	REIDISPONGIOLIDE C	A	2ASP	0.87
803	LOVASTATIN	A,B	1CQP	0.81
RGA	REIDISPONGIOLIDE A	A	2ASM	0.75
SRN	SORANGICIN A	C,D	1YNJ	0.73
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.72